Everhart Financial Group Inc. Acquires 255 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Everhart Financial Group Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 13.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,194 shares of the healthcare conglomerate’s stock after acquiring an additional 255 shares during the quarter. Everhart Financial Group Inc.’s holdings in UnitedHealth Group were worth $1,127,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Advocacy Wealth Management Services LLC lifted its position in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. lifted its position in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 30 shares during the last quarter. Rise Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $38,000. Evolution Advisers Inc. bought a new stake in UnitedHealth Group in the first quarter valued at approximately $38,000. Finally, Cordant Inc. bought a new position in shares of UnitedHealth Group during the first quarter valued at approximately $45,000. Institutional investors own 87.25% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. Loop Capital initiated coverage on UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 target price for the company. Oppenheimer upped their target price on UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Argus upped their target price on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research note on Thursday, September 8th. Finally, Credit Suisse Group upped their price target on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $585.65.

UnitedHealth Group Stock Down 2.1 %

Shares of UNH opened at $512.08 on Thursday. The company has a market capitalization of $478.99 billion, a PE ratio of 26.74, a price-to-earnings-growth ratio of 1.64 and a beta of 0.76. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The stock has a fifty day simple moving average of $529.81 and a two-hundred day simple moving average of $512.24.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter last year, the business earned $4.70 earnings per share. The business’s revenue for the quarter was up 12.6% compared to the same quarter last year. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

Insider Activity

In other news, CEO Dirk C. Mcmahon sold 14,715 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $543.32, for a total transaction of $7,994,953.80. Following the completion of the transaction, the chief executive officer now directly owns 50,108 shares in the company, valued at approximately $27,224,678.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Dirk C. Mcmahon sold 14,715 shares of the business’s stock in a transaction dated Thursday, August 18th. The shares were sold at an average price of $543.32, for a total value of $7,994,953.80. Following the completion of the transaction, the chief executive officer now owns 50,108 shares in the company, valued at $27,224,678.56. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 139,051 shares of company stock worth $74,450,958. Insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.